カテゴリー： 世界, 医療/バイオ, LP Information

世界のアンギオテンシノーゲンモノクローナル抗体市場予測 2023年-2029年

【英語タイトル】Global Angiotensinogen Monoclonal Antibody Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC04277）・商品コード：LP23DC04277
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：107
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のアンギオテンシノーゲンモノクローナル抗体市場」は、過去の販売実績から2022年の世界のアンギオテンシノーゲンモノクローナル抗体の総販売量を検討し、2023年から2029年の予測されるアンギオテンシノーゲンモノクローナル抗体の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のアンギオテンシノーゲンモノクローナル抗体の市場規模を掲載し、XXX百万米ドル規模の世界のアンギオテンシノーゲンモノクローナル抗体市場の詳細な分析を提供します。本インサイトレポートは、世界のアンギオテンシノーゲンモノクローナル抗体業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のアンギオテンシノーゲンモノクローナル抗体市場における各社の独自のポジションをより深く理解するために、アンギオテンシノーゲンモノクローナル抗体製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のアンギオテンシノーゲンモノクローナル抗体市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。アンギオテンシノーゲンモノクローナル抗体の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。アンギオテンシノーゲンモノクローナル抗体の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。アンギオテンシノーゲンモノクローナル抗体のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

アンギオテンシノーゲンモノクローナル抗体の世界主要メーカーとしては、Sino Biological, Inc.、 Elabscience Biotechnology Inc.、 Wuhan Fine Biotech Co., Ltd.、 Biomatik、 MyBiosource, Inc.、 Assay Genie、 Abbexa、 Biorbyt、 RayBiotech, Inc.、 ZodelBiotec Ltd.、 Innovative Researchなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のアンギオテンシノーゲンモノクローナル抗体市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではアンギオテンシノーゲンモノクローナル抗体市場をセグメンテーションし、種類別 (リコンビナント、非リコンビナント)、用途別 (フローサイトメトリー、ELISA、ウェスタンブロット、免疫沈降、免疫蛍光、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：リコンビナント、非リコンビナント

・用途別区分：フローサイトメトリー、ELISA、ウェスタンブロット、免疫沈降、免疫蛍光、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のアンギオテンシノーゲンモノクローナル抗体市場の10年間の市場状況・展望は？
・世界および地域別に見たアンギオテンシノーゲンモノクローナル抗体市場成長の要因は何か？
・アンギオテンシノーゲンモノクローナル抗体の市場機会はエンドマーケットの規模によってどのように変化するのか？
・アンギオテンシノーゲンモノクローナル抗体のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：アンギオテンシノーゲンモノクローナル抗体の年間販売量2018-2029、地域別現状・将来分析
・アンギオテンシノーゲンモノクローナル抗体の種類別セグメント：リコンビナント、非リコンビナント
・アンギオテンシノーゲンモノクローナル抗体の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・アンギオテンシノーゲンモノクローナル抗体の用途別セグメント：フローサイトメトリー、ELISA、ウェスタンブロット、免疫沈降、免疫蛍光、その他
・アンギオテンシノーゲンモノクローナル抗体の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のアンギオテンシノーゲンモノクローナル抗体市場
・企業別のグローバルアンギオテンシノーゲンモノクローナル抗体市場データ：2018-2023年の年間販売量、市場シェア
・企業別のアンギオテンシノーゲンモノクローナル抗体の年間売上：2018-2023年の売上、市場シェア
・企業別のアンギオテンシノーゲンモノクローナル抗体販売価格
・主要企業のアンギオテンシノーゲンモノクローナル抗体生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

アンギオテンシノーゲンモノクローナル抗体の地域別レビュー
・地域別のアンギオテンシノーゲンモノクローナル抗体市場規模2018-2023：年間販売量、売上
・主要国別のアンギオテンシノーゲンモノクローナル抗体市場規模2018-2023：年間販売量、売上
・南北アメリカのアンギオテンシノーゲンモノクローナル抗体販売の成長
・アジア太平洋のアンギオテンシノーゲンモノクローナル抗体販売の成長
・ヨーロッパのアンギオテンシノーゲンモノクローナル抗体販売の成長
・中東・アフリカのアンギオテンシノーゲンモノクローナル抗体販売の成長

南北アメリカ市場
・南北アメリカの国別のアンギオテンシノーゲンモノクローナル抗体販売量、売上（2018-2023）
・南北アメリカのアンギオテンシノーゲンモノクローナル抗体の種類別販売量
・南北アメリカのアンギオテンシノーゲンモノクローナル抗体の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のアンギオテンシノーゲンモノクローナル抗体販売量、売上（2018-2023）
・アジア太平洋のアンギオテンシノーゲンモノクローナル抗体の種類別販売量
・アジア太平洋のアンギオテンシノーゲンモノクローナル抗体の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のアンギオテンシノーゲンモノクローナル抗体販売量、売上（2018-2023）
・ヨーロッパのアンギオテンシノーゲンモノクローナル抗体の種類別販売量
・ヨーロッパのアンギオテンシノーゲンモノクローナル抗体の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のアンギオテンシノーゲンモノクローナル抗体販売量、売上（2018-2023）
・中東・アフリカのアンギオテンシノーゲンモノクローナル抗体の種類別販売量
・中東・アフリカのアンギオテンシノーゲンモノクローナル抗体の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・アンギオテンシノーゲンモノクローナル抗体の製造コスト構造分析
・アンギオテンシノーゲンモノクローナル抗体の製造プロセス分析
・アンギオテンシノーゲンモノクローナル抗体の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・アンギオテンシノーゲンモノクローナル抗体の主要なグローバル販売業者
・アンギオテンシノーゲンモノクローナル抗体の主要なグローバル顧客

地域別のアンギオテンシノーゲンモノクローナル抗体市場予測レビュー
・地域別のアンギオテンシノーゲンモノクローナル抗体市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・アンギオテンシノーゲンモノクローナル抗体の種類別市場規模予測
・アンギオテンシノーゲンモノクローナル抗体の用途別市場規模予測

主要企業分析
Sino Biological, Inc.、 Elabscience Biotechnology Inc.、 Wuhan Fine Biotech Co., Ltd.、 Biomatik、 MyBiosource, Inc.、 Assay Genie、 Abbexa、 Biorbyt、 RayBiotech, Inc.、 ZodelBiotec Ltd.、 Innovative Research
・企業情報
・アンギオテンシノーゲンモノクローナル抗体製品
・アンギオテンシノーゲンモノクローナル抗体販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Angiotensinogen Monoclonal Antibody market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Angiotensinogen Monoclonal Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Angiotensinogen Monoclonal Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Angiotensinogen Monoclonal Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Angiotensinogen Monoclonal Antibody players cover Sino Biological, Inc., Elabscience Biotechnology Inc., Wuhan Fine Biotech Co., Ltd., Biomatik, MyBiosource, Inc., Assay Genie, Abbexa, Biorbyt and RayBiotech, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Angiotensinogen Monoclonal Antibody is an unconjugated antibody to Angiotensinogen.
LPI (LP Information)’ newest research report, the “Angiotensinogen Monoclonal Antibody Industry Forecast” looks at past sales and reviews total world Angiotensinogen Monoclonal Antibody sales in 2022, providing a comprehensive analysis by region and market sector of projected Angiotensinogen Monoclonal Antibody sales for 2023 through 2029. With Angiotensinogen Monoclonal Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Angiotensinogen Monoclonal Antibody industry.
This Insight Report provides a comprehensive analysis of the global Angiotensinogen Monoclonal Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Angiotensinogen Monoclonal Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Angiotensinogen Monoclonal Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Angiotensinogen Monoclonal Antibody and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Angiotensinogen Monoclonal Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of Angiotensinogen Monoclonal Antibody market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Recombinant
Non-recombinant
Segmentation by application
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Sino Biological, Inc.
Elabscience Biotechnology Inc.
Wuhan Fine Biotech Co., Ltd.
Biomatik
MyBiosource, Inc.
Assay Genie
Abbexa
Biorbyt
RayBiotech, Inc.
ZodelBiotec Ltd.
Innovative Research
Key Questions Addressed in this Report
What is the 10-year outlook for the global Angiotensinogen Monoclonal Antibody market?
What factors are driving Angiotensinogen Monoclonal Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Angiotensinogen Monoclonal Antibody market opportunities vary by end market size?
How does Angiotensinogen Monoclonal Antibody break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Angiotensinogen Monoclonal Antibody Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Angiotensinogen Monoclonal Antibody by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Angiotensinogen Monoclonal Antibody by Country/Region, 2018, 2022 & 2029
2.2 Angiotensinogen Monoclonal Antibody Segment by Type
2.2.1 Recombinant
2.2.2 Non-recombinant
2.3 Angiotensinogen Monoclonal Antibody Sales by Type
2.3.1 Global Angiotensinogen Monoclonal Antibody Sales Market Share by Type (2018-2023)
2.3.2 Global Angiotensinogen Monoclonal Antibody Revenue and Market Share by Type (2018-2023)
2.3.3 Global Angiotensinogen Monoclonal Antibody Sale Price by Type (2018-2023)
2.4 Angiotensinogen Monoclonal Antibody Segment by Application
2.4.1 Flow Cytometry
2.4.2 ELISA
2.4.3 Western Blot
2.4.4 Immunoprecipitation
2.4.5 Immunofluorescence
2.4.6 Other
2.5 Angiotensinogen Monoclonal Antibody Sales by Application
2.5.1 Global Angiotensinogen Monoclonal Antibody Sale Market Share by Application (2018-2023)
2.5.2 Global Angiotensinogen Monoclonal Antibody Revenue and Market Share by Application (2018-2023)
2.5.3 Global Angiotensinogen Monoclonal Antibody Sale Price by Application (2018-2023)
3 Global Angiotensinogen Monoclonal Antibody by Company
3.1 Global Angiotensinogen Monoclonal Antibody Breakdown Data by Company
3.1.1 Global Angiotensinogen Monoclonal Antibody Annual Sales by Company (2018-2023)
3.1.2 Global Angiotensinogen Monoclonal Antibody Sales Market Share by Company (2018-2023)
3.2 Global Angiotensinogen Monoclonal Antibody Annual Revenue by Company (2018-2023)
3.2.1 Global Angiotensinogen Monoclonal Antibody Revenue by Company (2018-2023)
3.2.2 Global Angiotensinogen Monoclonal Antibody Revenue Market Share by Company (2018-2023)
3.3 Global Angiotensinogen Monoclonal Antibody Sale Price by Company
3.4 Key Manufacturers Angiotensinogen Monoclonal Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Angiotensinogen Monoclonal Antibody Product Location Distribution
3.4.2 Players Angiotensinogen Monoclonal Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Angiotensinogen Monoclonal Antibody by Geographic Region
4.1 World Historic Angiotensinogen Monoclonal Antibody Market Size by Geographic Region (2018-2023)
4.1.1 Global Angiotensinogen Monoclonal Antibody Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Angiotensinogen Monoclonal Antibody Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Angiotensinogen Monoclonal Antibody Market Size by Country/Region (2018-2023)
4.2.1 Global Angiotensinogen Monoclonal Antibody Annual Sales by Country/Region (2018-2023)
4.2.2 Global Angiotensinogen Monoclonal Antibody Annual Revenue by Country/Region (2018-2023)
4.3 Americas Angiotensinogen Monoclonal Antibody Sales Growth
4.4 APAC Angiotensinogen Monoclonal Antibody Sales Growth
4.5 Europe Angiotensinogen Monoclonal Antibody Sales Growth
4.6 Middle East & Africa Angiotensinogen Monoclonal Antibody Sales Growth
5 Americas
5.1 Americas Angiotensinogen Monoclonal Antibody Sales by Country
5.1.1 Americas Angiotensinogen Monoclonal Antibody Sales by Country (2018-2023)
5.1.2 Americas Angiotensinogen Monoclonal Antibody Revenue by Country (2018-2023)
5.2 Americas Angiotensinogen Monoclonal Antibody Sales by Type
5.3 Americas Angiotensinogen Monoclonal Antibody Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Angiotensinogen Monoclonal Antibody Sales by Region
6.1.1 APAC Angiotensinogen Monoclonal Antibody Sales by Region (2018-2023)
6.1.2 APAC Angiotensinogen Monoclonal Antibody Revenue by Region (2018-2023)
6.2 APAC Angiotensinogen Monoclonal Antibody Sales by Type
6.3 APAC Angiotensinogen Monoclonal Antibody Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Angiotensinogen Monoclonal Antibody by Country
7.1.1 Europe Angiotensinogen Monoclonal Antibody Sales by Country (2018-2023)
7.1.2 Europe Angiotensinogen Monoclonal Antibody Revenue by Country (2018-2023)
7.2 Europe Angiotensinogen Monoclonal Antibody Sales by Type
7.3 Europe Angiotensinogen Monoclonal Antibody Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Angiotensinogen Monoclonal Antibody by Country
8.1.1 Middle East & Africa Angiotensinogen Monoclonal Antibody Sales by Country (2018-2023)
8.1.2 Middle East & Africa Angiotensinogen Monoclonal Antibody Revenue by Country (2018-2023)
8.2 Middle East & Africa Angiotensinogen Monoclonal Antibody Sales by Type
8.3 Middle East & Africa Angiotensinogen Monoclonal Antibody Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Angiotensinogen Monoclonal Antibody
10.3 Manufacturing Process Analysis of Angiotensinogen Monoclonal Antibody
10.4 Industry Chain Structure of Angiotensinogen Monoclonal Antibody
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Angiotensinogen Monoclonal Antibody Distributors
11.3 Angiotensinogen Monoclonal Antibody Customer
12 World Forecast Review for Angiotensinogen Monoclonal Antibody by Geographic Region
12.1 Global Angiotensinogen Monoclonal Antibody Market Size Forecast by Region
12.1.1 Global Angiotensinogen Monoclonal Antibody Forecast by Region (2024-2029)
12.1.2 Global Angiotensinogen Monoclonal Antibody Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Angiotensinogen Monoclonal Antibody Forecast by Type
12.7 Global Angiotensinogen Monoclonal Antibody Forecast by Application
13 Key Players Analysis
13.1 Sino Biological, Inc.
13.1.1 Sino Biological, Inc. Company Information
13.1.2 Sino Biological, Inc. Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
13.1.3 Sino Biological, Inc. Angiotensinogen Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sino Biological, Inc. Main Business Overview
13.1.5 Sino Biological, Inc. Latest Developments
13.2 Elabscience Biotechnology Inc.
13.2.1 Elabscience Biotechnology Inc. Company Information
13.2.2 Elabscience Biotechnology Inc. Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
13.2.3 Elabscience Biotechnology Inc. Angiotensinogen Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Elabscience Biotechnology Inc. Main Business Overview
13.2.5 Elabscience Biotechnology Inc. Latest Developments
13.3 Wuhan Fine Biotech Co., Ltd.
13.3.1 Wuhan Fine Biotech Co., Ltd. Company Information
13.3.2 Wuhan Fine Biotech Co., Ltd. Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
13.3.3 Wuhan Fine Biotech Co., Ltd. Angiotensinogen Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Wuhan Fine Biotech Co., Ltd. Main Business Overview
13.3.5 Wuhan Fine Biotech Co., Ltd. Latest Developments
13.4 Biomatik
13.4.1 Biomatik Company Information
13.4.2 Biomatik Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
13.4.3 Biomatik Angiotensinogen Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Biomatik Main Business Overview
13.4.5 Biomatik Latest Developments
13.5 MyBiosource, Inc.
13.5.1 MyBiosource, Inc. Company Information
13.5.2 MyBiosource, Inc. Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
13.5.3 MyBiosource, Inc. Angiotensinogen Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 MyBiosource, Inc. Main Business Overview
13.5.5 MyBiosource, Inc. Latest Developments
13.6 Assay Genie
13.6.1 Assay Genie Company Information
13.6.2 Assay Genie Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
13.6.3 Assay Genie Angiotensinogen Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Assay Genie Main Business Overview
13.6.5 Assay Genie Latest Developments
13.7 Abbexa
13.7.1 Abbexa Company Information
13.7.2 Abbexa Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
13.7.3 Abbexa Angiotensinogen Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Abbexa Main Business Overview
13.7.5 Abbexa Latest Developments
13.8 Biorbyt
13.8.1 Biorbyt Company Information
13.8.2 Biorbyt Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
13.8.3 Biorbyt Angiotensinogen Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biorbyt Main Business Overview
13.8.5 Biorbyt Latest Developments
13.9 RayBiotech, Inc.
13.9.1 RayBiotech, Inc. Company Information
13.9.2 RayBiotech, Inc. Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
13.9.3 RayBiotech, Inc. Angiotensinogen Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 RayBiotech, Inc. Main Business Overview
13.9.5 RayBiotech, Inc. Latest Developments
13.10 ZodelBiotec Ltd.
13.10.1 ZodelBiotec Ltd. Company Information
13.10.2 ZodelBiotec Ltd. Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
13.10.3 ZodelBiotec Ltd. Angiotensinogen Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 ZodelBiotec Ltd. Main Business Overview
13.10.5 ZodelBiotec Ltd. Latest Developments
13.11 Innovative Research
13.11.1 Innovative Research Company Information
13.11.2 Innovative Research Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
13.11.3 Innovative Research Angiotensinogen Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Innovative Research Main Business Overview
13.11.5 Innovative Research Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Angiotensinogen Monoclonal Antibody Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Angiotensinogen Monoclonal Antibody Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Recombinant
Table 4. Major Players of Non-recombinant
Table 5. Global Angiotensinogen Monoclonal Antibody Sales by Type (2018-2023) & (K Units)
Table 6. Global Angiotensinogen Monoclonal Antibody Sales Market Share by Type (2018-2023)
Table 7. Global Angiotensinogen Monoclonal Antibody Revenue by Type (2018-2023) & ($ million)
Table 8. Global Angiotensinogen Monoclonal Antibody Revenue Market Share by Type (2018-2023)
Table 9. Global Angiotensinogen Monoclonal Antibody Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Angiotensinogen Monoclonal Antibody Sales by Application (2018-2023) & (K Units)
Table 11. Global Angiotensinogen Monoclonal Antibody Sales Market Share by Application (2018-2023)
Table 12. Global Angiotensinogen Monoclonal Antibody Revenue by Application (2018-2023)
Table 13. Global Angiotensinogen Monoclonal Antibody Revenue Market Share by Application (2018-2023)
Table 14. Global Angiotensinogen Monoclonal Antibody Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Angiotensinogen Monoclonal Antibody Sales by Company (2018-2023) & (K Units)
Table 16. Global Angiotensinogen Monoclonal Antibody Sales Market Share by Company (2018-2023)
Table 17. Global Angiotensinogen Monoclonal Antibody Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Angiotensinogen Monoclonal Antibody Revenue Market Share by Company (2018-2023)
Table 19. Global Angiotensinogen Monoclonal Antibody Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Angiotensinogen Monoclonal Antibody Producing Area Distribution and Sales Area
Table 21. Players Angiotensinogen Monoclonal Antibody Products Offered
Table 22. Angiotensinogen Monoclonal Antibody Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Angiotensinogen Monoclonal Antibody Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Angiotensinogen Monoclonal Antibody Sales Market Share Geographic Region (2018-2023)
Table 27. Global Angiotensinogen Monoclonal Antibody Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Angiotensinogen Monoclonal Antibody Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Angiotensinogen Monoclonal Antibody Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Angiotensinogen Monoclonal Antibody Sales Market Share by Country/Region (2018-2023)
Table 31. Global Angiotensinogen Monoclonal Antibody Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Angiotensinogen Monoclonal Antibody Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Angiotensinogen Monoclonal Antibody Sales by Country (2018-2023) & (K Units)
Table 34. Americas Angiotensinogen Monoclonal Antibody Sales Market Share by Country (2018-2023)
Table 35. Americas Angiotensinogen Monoclonal Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Angiotensinogen Monoclonal Antibody Revenue Market Share by Country (2018-2023)
Table 37. Americas Angiotensinogen Monoclonal Antibody Sales by Type (2018-2023) & (K Units)
Table 38. Americas Angiotensinogen Monoclonal Antibody Sales by Application (2018-2023) & (K Units)
Table 39. APAC Angiotensinogen Monoclonal Antibody Sales by Region (2018-2023) & (K Units)
Table 40. APAC Angiotensinogen Monoclonal Antibody Sales Market Share by Region (2018-2023)
Table 41. APAC Angiotensinogen Monoclonal Antibody Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Angiotensinogen Monoclonal Antibody Revenue Market Share by Region (2018-2023)
Table 43. APAC Angiotensinogen Monoclonal Antibody Sales by Type (2018-2023) & (K Units)
Table 44. APAC Angiotensinogen Monoclonal Antibody Sales by Application (2018-2023) & (K Units)
Table 45. Europe Angiotensinogen Monoclonal Antibody Sales by Country (2018-2023) & (K Units)
Table 46. Europe Angiotensinogen Monoclonal Antibody Sales Market Share by Country (2018-2023)
Table 47. Europe Angiotensinogen Monoclonal Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Angiotensinogen Monoclonal Antibody Revenue Market Share by Country (2018-2023)
Table 49. Europe Angiotensinogen Monoclonal Antibody Sales by Type (2018-2023) & (K Units)
Table 50. Europe Angiotensinogen Monoclonal Antibody Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Angiotensinogen Monoclonal Antibody Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Angiotensinogen Monoclonal Antibody Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Angiotensinogen Monoclonal Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Angiotensinogen Monoclonal Antibody Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Angiotensinogen Monoclonal Antibody Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Angiotensinogen Monoclonal Antibody Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Angiotensinogen Monoclonal Antibody
Table 58. Key Market Challenges & Risks of Angiotensinogen Monoclonal Antibody
Table 59. Key Industry Trends of Angiotensinogen Monoclonal Antibody
Table 60. Angiotensinogen Monoclonal Antibody Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Angiotensinogen Monoclonal Antibody Distributors List
Table 63. Angiotensinogen Monoclonal Antibody Customer List
Table 64. Global Angiotensinogen Monoclonal Antibody Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Angiotensinogen Monoclonal Antibody Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Angiotensinogen Monoclonal Antibody Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Angiotensinogen Monoclonal Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Angiotensinogen Monoclonal Antibody Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Angiotensinogen Monoclonal Antibody Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Angiotensinogen Monoclonal Antibody Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Angiotensinogen Monoclonal Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Angiotensinogen Monoclonal Antibody Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Angiotensinogen Monoclonal Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Angiotensinogen Monoclonal Antibody Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Angiotensinogen Monoclonal Antibody Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Angiotensinogen Monoclonal Antibody Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Angiotensinogen Monoclonal Antibody Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sino Biological, Inc. Basic Information, Angiotensinogen Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 79. Sino Biological, Inc. Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
Table 80. Sino Biological, Inc. Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Sino Biological, Inc. Main Business
Table 82. Sino Biological, Inc. Latest Developments
Table 83. Elabscience Biotechnology Inc. Basic Information, Angiotensinogen Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 84. Elabscience Biotechnology Inc. Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
Table 85. Elabscience Biotechnology Inc. Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Elabscience Biotechnology Inc. Main Business
Table 87. Elabscience Biotechnology Inc. Latest Developments
Table 88. Wuhan Fine Biotech Co., Ltd. Basic Information, Angiotensinogen Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 89. Wuhan Fine Biotech Co., Ltd. Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
Table 90. Wuhan Fine Biotech Co., Ltd. Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Wuhan Fine Biotech Co., Ltd. Main Business
Table 92. Wuhan Fine Biotech Co., Ltd. Latest Developments
Table 93. Biomatik Basic Information, Angiotensinogen Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 94. Biomatik Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
Table 95. Biomatik Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Biomatik Main Business
Table 97. Biomatik Latest Developments
Table 98. MyBiosource, Inc. Basic Information, Angiotensinogen Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 99. MyBiosource, Inc. Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
Table 100. MyBiosource, Inc. Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. MyBiosource, Inc. Main Business
Table 102. MyBiosource, Inc. Latest Developments
Table 103. Assay Genie Basic Information, Angiotensinogen Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 104. Assay Genie Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
Table 105. Assay Genie Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Assay Genie Main Business
Table 107. Assay Genie Latest Developments
Table 108. Abbexa Basic Information, Angiotensinogen Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 109. Abbexa Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
Table 110. Abbexa Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Abbexa Main Business
Table 112. Abbexa Latest Developments
Table 113. Biorbyt Basic Information, Angiotensinogen Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 114. Biorbyt Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
Table 115. Biorbyt Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Biorbyt Main Business
Table 117. Biorbyt Latest Developments
Table 118. RayBiotech, Inc. Basic Information, Angiotensinogen Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 119. RayBiotech, Inc. Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
Table 120. RayBiotech, Inc. Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. RayBiotech, Inc. Main Business
Table 122. RayBiotech, Inc. Latest Developments
Table 123. ZodelBiotec Ltd. Basic Information, Angiotensinogen Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 124. ZodelBiotec Ltd. Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
Table 125. ZodelBiotec Ltd. Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. ZodelBiotec Ltd. Main Business
Table 127. ZodelBiotec Ltd. Latest Developments
Table 128. Innovative Research Basic Information, Angiotensinogen Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 129. Innovative Research Angiotensinogen Monoclonal Antibody Product Portfolios and Specifications
Table 130. Innovative Research Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Innovative Research Main Business
Table 132. Innovative Research Latest Developments
List of Figures
Figure 1. Picture of Angiotensinogen Monoclonal Antibody
Figure 2. Angiotensinogen Monoclonal Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Angiotensinogen Monoclonal Antibody Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Angiotensinogen Monoclonal Antibody Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Angiotensinogen Monoclonal Antibody Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Recombinant
Figure 10. Product Picture of Non-recombinant
Figure 11. Global Angiotensinogen Monoclonal Antibody Sales Market Share by Type in 2022
Figure 12. Global Angiotensinogen Monoclonal Antibody Revenue Market Share by Type (2018-2023)
Figure 13. Angiotensinogen Monoclonal Antibody Consumed in Flow Cytometry
Figure 14. Global Angiotensinogen Monoclonal Antibody Market: Flow Cytometry (2018-2023) & (K Units)
Figure 15. Angiotensinogen Monoclonal Antibody Consumed in ELISA
Figure 16. Global Angiotensinogen Monoclonal Antibody Market: ELISA (2018-2023) & (K Units)
Figure 17. Angiotensinogen Monoclonal Antibody Consumed in Western Blot
Figure 18. Global Angiotensinogen Monoclonal Antibody Market: Western Blot (2018-2023) & (K Units)
Figure 19. Angiotensinogen Monoclonal Antibody Consumed in Immunoprecipitation
Figure 20. Global Angiotensinogen Monoclonal Antibody Market: Immunoprecipitation (2018-2023) & (K Units)
Figure 21. Angiotensinogen Monoclonal Antibody Consumed in Immunofluorescence
Figure 22. Global Angiotensinogen Monoclonal Antibody Market: Immunofluorescence (2018-2023) & (K Units)
Figure 23. Angiotensinogen Monoclonal Antibody Consumed in Other
Figure 24. Global Angiotensinogen Monoclonal Antibody Market: Other (2018-2023) & (K Units)
Figure 25. Global Angiotensinogen Monoclonal Antibody Sales Market Share by Application (2022)
Figure 26. Global Angiotensinogen Monoclonal Antibody Revenue Market Share by Application in 2022
Figure 27. Angiotensinogen Monoclonal Antibody Sales Market by Company in 2022 (K Units)
Figure 28. Global Angiotensinogen Monoclonal Antibody Sales Market Share by Company in 2022
Figure 29. Angiotensinogen Monoclonal Antibody Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Angiotensinogen Monoclonal Antibody Revenue Market Share by Company in 2022
Figure 31. Global Angiotensinogen Monoclonal Antibody Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Angiotensinogen Monoclonal Antibody Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Angiotensinogen Monoclonal Antibody Sales 2018-2023 (K Units)
Figure 34. Americas Angiotensinogen Monoclonal Antibody Revenue 2018-2023 ($ Millions)
Figure 35. APAC Angiotensinogen Monoclonal Antibody Sales 2018-2023 (K Units)
Figure 36. APAC Angiotensinogen Monoclonal Antibody Revenue 2018-2023 ($ Millions)
Figure 37. Europe Angiotensinogen Monoclonal Antibody Sales 2018-2023 (K Units)
Figure 38. Europe Angiotensinogen Monoclonal Antibody Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Angiotensinogen Monoclonal Antibody Sales 2018-2023 (K Units)
Figure 40. Middle East & Africa Angiotensinogen Monoclonal Antibody Revenue 2018-2023 ($ Millions)
Figure 41. Americas Angiotensinogen Monoclonal Antibody Sales Market Share by Country in 2022
Figure 42. Americas Angiotensinogen Monoclonal Antibody Revenue Market Share by Country in 2022
Figure 43. Americas Angiotensinogen Monoclonal Antibody Sales Market Share by Type (2018-2023)
Figure 44. Americas Angiotensinogen Monoclonal Antibody Sales Market Share by Application (2018-2023)
Figure 45. United States Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Angiotensinogen Monoclonal Antibody Sales Market Share by Region in 2022
Figure 50. APAC Angiotensinogen Monoclonal Antibody Revenue Market Share by Regions in 2022
Figure 51. APAC Angiotensinogen Monoclonal Antibody Sales Market Share by Type (2018-2023)
Figure 52. APAC Angiotensinogen Monoclonal Antibody Sales Market Share by Application (2018-2023)
Figure 53. China Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Angiotensinogen Monoclonal Antibody Sales Market Share by Country in 2022
Figure 61. Europe Angiotensinogen Monoclonal Antibody Revenue Market Share by Country in 2022
Figure 62. Europe Angiotensinogen Monoclonal Antibody Sales Market Share by Type (2018-2023)
Figure 63. Europe Angiotensinogen Monoclonal Antibody Sales Market Share by Application (2018-2023)
Figure 64. Germany Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Angiotensinogen Monoclonal Antibody Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Angiotensinogen Monoclonal Antibody Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Angiotensinogen Monoclonal Antibody Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Angiotensinogen Monoclonal Antibody Sales Market Share by Application (2018-2023)
Figure 73. Egypt Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Angiotensinogen Monoclonal Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Angiotensinogen Monoclonal Antibody in 2022
Figure 79. Manufacturing Process Analysis of Angiotensinogen Monoclonal Antibody
Figure 80. Industry Chain Structure of Angiotensinogen Monoclonal Antibody
Figure 81. Channels of Distribution
Figure 82. Global Angiotensinogen Monoclonal Antibody Sales Market Forecast by Region (2024-2029)
Figure 83. Global Angiotensinogen Monoclonal Antibody Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Angiotensinogen Monoclonal Antibody Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Angiotensinogen Monoclonal Antibody Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Angiotensinogen Monoclonal Antibody Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Angiotensinogen Monoclonal Antibody Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のアンギオテンシノーゲンモノクローナル抗体市場予測 2023年-2029年] (コード：LP23DC04277)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアンギオテンシノーゲンモノクローナル抗体市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のアンギオテンシノーゲン抗体市場予測 2023年-2029年
  • 世界の抗ロドプシンモノクローナル抗体市場予測 2023年-2029年
  • 世界のホスホセリン抗体市場予測 2023年-2029年
  • 世界のAGK抗体市場予測 2023年-2029年
  • 世界のNEU3抗体市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆